By: ETFdb
Israel ETF (EIS): An Unlikely Winner In Health Care Reform
With the passage of the sweeping health care reform late Sunday night, many investors are scrambling to determine which sectors are likely to benefit from the new legislation. Although the timing and impact of changes remains to be seen, generic pharmaceutical firms will likely emerge as one of the big winners. Many big name drugs [...] Related Stories: Health Care ETFs In Focus After Historic Vote Israel ETF (EIS) Surges Ahead Pharma ETFs in Focus: Obama’s Reform and Swine Flu’s Sting
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here